The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The pathological process underlying Alzheimer’s disease in individuals under thirty
Abstract
Brains of 42 individuals between the ages of 4 and 29 were examined with antibodies (AT8, 4G8) and silver stains for the presence of intraneuronal and extracellular protein aggregates associated with Alzheimer's disease. Thirty-eight of 42 (38/42) cases displayed abnormally phosphorylated tau protein (pretangle material) in nerve cells or in portions of their cellular processes, and 41/42 individuals showed no extracellular amyloid-β protein deposition or neuritic plaques-an individual with Down syndrome was the only exception. In 16/42 cases abnormal tau was found in the transentorhinal region, and in 3/42 cases this site was Gallyas-positive for isolated NFTs (NFT stage I). Of 26 cases that lacked abnormal tau in the transentorhinal region, 4 did not show pretangle material at subcortical sites. The remaining 22 of these same 26 cases, however, had subcortical lesions confined to non-thalamic nuclei with diffuse projections to the cerebral cortex, and, remarkably, in 19/22 individuals the pretangle material was confined to the noradrenergic coeruleus/subcoeruleus complex. Assuming the pretangle alterations are not transient and do not regress, these findings may indicate that the Alzheimer's disease-related pathological process leading to neurofibrillary tangle formation does not begin in the cerebral cortex but, rather, in select subcortical nuclei, and it may start quite early, i.e., before puberty or in early young adulthood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, it has been reported that NFTs are also very common in certain brainstem nuclei in subjects without dementia (39-44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“At 40 years, all individuals studied by Braak and Del Tredici (39) and Braak et al (44) exhibited at least initial neurofibrillary pathology in the brainstem (Fig. 5).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“Neurofibrillary pathology is observed in the human brain long before Aβ plaques develop (39, 44, 300).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“Although some studies have interpreted phosphorylated tau abnormalities in the locus coeruleus to be an early stage of AD pathology [15], young control subjects were not screened for a history of exposure to mTBI despite the fact that mTBI is common among young individuals and that 17 % of the control subjects died from acute trauma or accidental death.”
From The neuropathology of sport (2014) · cites this paper as [15]
In the citing paper
“The focal collections of perivascular NFTs in the depths of the cortical sulci in CTE [65, 66, 126–128] differ substantially from PHF-tau pathology of the Alzheimer type reported in some cognitively normal young adults [15], opiate abusers [4], and non-demented elderly subjects such as those in the Framingham Heart Study [6] or Honolulu Asian Aging Study [67, 194].”
From The neuropathology of sport (2014) · cites this paper as [15]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 7×
“Characteristic changes in the lesional distribution pattern are used to distinguish stages in the course of the process [1, 4, 13 , 18, 20, 51, 91].”
BackgroundMethodInfluentialSelf-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Braak H, Braak E, Yilmazer D, Schultz C, Bohl J (1995) Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathologic diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 14–19
Cited by
Sorted by citations
Items 601–700 of 813
The potential utility of smell testing to screen for neurodegenerative disorders
Goodwin, G. R., Bestwick, J. P., & Noyce, A. J. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2037424 · Cited by 5
Differences in Tau Seeding in Newborn and Adult Wild-Type Mice
Ferrer, I., Andrés‐Benito, P., Garcia‐Esparcia, P., López‐González, I., Valiente, D., Jordán, M., Carmona, M., Sala‐Jarque, J., Gil, V., & del Rı́o, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094789 · Cited by 5
Novel immunological approaches for the treatment of Alzheimer's disease.
Sabharwal, P., & Wısnıewskı, T. (2014) · PubMed · doi:10.3969/j.issn.1672-6731.2014.03.001 · Cited by 5
Axonal Transport and Neurodegenerative Diseases
Roy, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00714-2 · Cited by 5
Calderón‐Garcidueñas, L. (2015) · doi:10.1002/9781118971758.ch20 · Cited by 5
Joshi, S. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/bqwte · Cited by 5
Liu, Y., Aquili, L., Wong, K.-H., Lu, Z.-L., & Lim, L. W. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102755 · Cited by 4
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology
Jacobs, H. I. L. (2026) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001455 · Cited by 4
Cammisuli, D. M., Tuena, C., Riva, G., Repetto, C., Axmacher, N., Chandreswaran, V., Isella, V., Pomati, S., Zago, S., Difonzo, T., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020192 · Cited by 4
Alzheimer's Disease and Effects of ABCA7 Polymorphisms: A Review
Gialama, V., Siokas, V., Liampas, I., Tsouris, Z., Stamati, P., Aslanidou, P., Provatas, A., Tsimourtou, V., Xiromerisiou, G., Bogdanos, D. P., et al. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2309164 · Cited by 4
Sani, N. F. A., Hamzah, A. I. Z. A., Bakar, Z. H. A., Yusof, Y. A. M., Makpol, S., Ngah, W. Z. W., & Damanhuri, H. A. (2021) · Cells · doi:10.3390/cells10071611 · Cited by 4
Parsimonious EBM: Generalising the event-based model of disease progression for simultaneous events
Parker, C. S., Oxtoby, N. P., Young, A. L., Initiative, A. D. N., Alexander, D. C., & Zhang, H. G. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121162 · Cited by 6
Abbate, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00308 · Cited by 4
In-Vitro Evaluation of Anticholinesterase and Antioxidant Activities of Cascuta Reflexa
Akhtar, M. S., Akbar, S., Erum, A., & Bhatti, S. A. (2019) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496475.2019.1579146 · Cited by 4
Neuropathological Basis of Alzheimer’s Disease and Alzheimer’s Disease Diagnosis
Schneider, J. A., Montine, T. J., Sperling, R. A., & Bennett, D. A. (2012) · Advances in biological psychiatry · doi:10.1159/000335384 · Cited by 4
HSV1 in Alzheimer’s disease: Myth or reality?
Špeljko, T., Jutrić, D., & Šimić, G. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0009-2 · Cited by 4
Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degenerationPreprint
Fernández-Cabello, S., Kronbichler, M., Dijk, K. R. A. V., Goodman, J. A., Spreng, R. N., Schmitz, T. W., & Initiative, A. D. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/676544 · Cited by 4
Zhang, C., Tai, Y., Kong, M., Jia, P., Ma, G., Ba, M., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322196 · Cited by 5
Stapleton, H. M., Borges, D. D. S., Trindade, E. B. S. D. M., & Yuan, Q. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00834-8 · Cited by 3
Sharma, A., Feng, L., Muresanu, D. F., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., Bryukhovetskiy, I., Manzhulo, I., Wiklund, L., et al. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.009 · Cited by 3
A comprehensive review on novel opportunities for Alzheimer therapy by targeting BIN1
Saha, T., & Karati, D. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00759-8 · Cited by 3
PET Imaging of the Human Brain with Microvolumetric Spatial Resolution
Doyon, V., Sarrhini, O., Loignon-Houle, F., Toussaint, M., Auger, É., Thibaudeau, C., Croteau, É., Lavallée, É., Beaudoin, J.-F., Leroux, J., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268809 · Cited by 3
Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_9 · Cited by 3
Self-citationThickness NETwork (ThickNet) Features for the Detection of Prodromal AD
Initiative, A. D. N., Raamana, P. R., Wang, L., & Beg, M. F. (2013) · Lecture notes in computer science · doi:10.1007/978-3-319-02267-3_15 · Cited by 3
Adcock, K. S., LAWLOR, B. A., Robertson, I. H., & Vanneste, S. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100989 · Cited by 3
Zhai, Z., Kong, F., Zhu, Z., Dai, J., Cai, J., Xie, D., Shen, Y., Xu, Y., & Sun, T. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.11.011 · Cited by 4
Feleke, R., Jogaudaite, S., Velentza‐Almpani, E., Yeung-Yeung, L., Clode, D., Ko, J. H., Shin, B., Matthews, S., Otero‐Jimenez, M., Wojewska, M. J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02869-4 · Cited by 4
Symptomatic and preclinical Alzheimer’s disease: Neuropathology and imaging
Thal, D. R. (2016) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2016.01.001 · Cited by 3
Schrötter, A., Park, Y. M., Marcus, K., Martins‐de‐Souza, D., Nilsson, P., Magraoui, F. E., Meyer, H. E., & Grinberg, L. T. (2016) · PROTEOMICS · doi:10.1002/pmic.201600047 · Cited by 3
Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer’s Disease
Wischik, C. M., Storey, J. M. D., Wischik, D., & Harrington, C. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00015-0 · Cited by 3
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 3
Schramm, P. J., Das, N., Schneiderman, E. D., German, Z., Hui, J., Wilson, D., Spence, J. S., de Moura, P. M., & Chapman, S. B. (2021) · Geriatrics · doi:10.3390/geriatrics6040107 · Cited by 3
Gallant, S. N., Kennedy, B. L., Bachman, S. L., Huang, R., Lee, T., & Mather, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.02.450802 · Cited by 3
Berger, A., Koshmanova, E., Beckers, E., Sharifpour, R., Paparella, I., Campbell, I., Mortazavi, N., Balda, F., Yi, Y., Lamalle, L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.524213 · Cited by 3
The emotion paradox in the aging body and brainPreprint
Mather, M. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/v8p3e · Cited by 5
Age‑related brainstem degeneration through microRNA modulation in mice
Kawakita, R., Takata, T., Nonaka, W., Hamada, Y., Iwama, H., Kobara, H., Deguchi, K., Miyamoto, O., Nakamura, T., Itano, T., et al. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13032 · Cited by 2
Engel, S., Dillerud, M., Scalf, M., Dobbelmann, R., Du, Y., Lee, A. M., & Graves, S. M. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.05.004 · Cited by 2
Cerebellar contributions to tau-mediated cognitive and behavioral dysfunction
Angeles-Perez, L., Ren, C., Neniel, J., Widner, J., Yamashiro, K., Tak, Y., Batra, S., Tan, T., Nguyen, B., Diamond, M. I., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116036 · Cited by 2
Bell‐Simons, M., Breuer, H., Wunderlich, L., Chmes, H., Adam, D., Klimek, J., Buchholz, S., & Zempel, H. (2025) · Aging Cell · doi:10.1111/acel.70215 · Cited by 2
rTg4510 Tauopathy Mice Exhibit Non-Spatial Memory Deficits Prevented by Doxycycline Treatment
Kishimoto, Y., Kubota, T., Nakashima, K., & Kirino, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15111183 · Cited by 2
Kron, J. O. Z. J., Metha, J. A., Daykin, H. J., Walker, L. C., Potts, Y., Allocca, G., Keenan, R. J., Hoyer, D., & Jacobson, L. H. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.12.001 · Cited by 3
Kam, K., Gaggi, N. L., Parekh, A., Valencia, D. I., Licona, D. A. Q., Hishinuma, S., Martillo, K., Chu, S. S. H., Varga, A. W., Hwang, J., et al. (2025) · SLEEP · doi:10.1093/sleep/zsaf398 · Cited by 2
Richardson, T. E., Cherry, J. D., Kandoi, S., Rohde, S. K., Uretsky, M., Tuz‐Zahra, F., Bieniek, K. F., Farrell, K. W., Hefti, M. M., Miller, M. B., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03031-4 · Cited by 3
A new hope: locus coeruleus-norepinephrine system at the nexus of neuropsychiatric symptoms
Korukonda, A., & Weinshenker, D. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03696-z · Cited by 2
Zheng, X., Tang, C., Li, H., Wang, B., Zheng, Y., Song, W., Wu, A., Xin, L., Zhang, D., Yang, R., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261459037 · Cited by 2
Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_5 · Cited by 2
Self-citationde Oliveira, F. H., Neto, E. R., Fonseca, M. K., Costa, A. S. R., Rockenbach, M. A. B. C., Padilha, R. D. S., Fernandez, L. L., & Hilbig, A. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150066 · Cited by 2
The neural economics of brain aging
Kosyakovsky, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91621-5 · Cited by 3
High impact research: investigating the effects of repetitive head injury
(2016) · Brain · doi:10.1093/brain/aww294 · Cited by 2
Prominent Perspective on Existing Biological Hallmarks of Alzheimer’s Disease
Singh, N., Sharma, S., Ghosh, K. K., Gupta, B., & Kuča, K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266292514240404040341 · Cited by 2
Chockanathan, U., & Padmanabhan, K. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012085 · Cited by 2
Alzheimer’s Disease: An Attempt of Total Recall
Bolshakov, A. P., Gerasimov, K., & Dobryakova, Y. V. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240620 · Cited by 2
The Prion-Like Aspect of Alzheimer Pathology
Fritschi, S. K., Eftekharzadeh, B., Manfredi, G., Hamaguchi, T., Heilbronner, G., Nagarathinam, A., Langer, F., Eisele, Y. S., Walker, L. C., & Jucker, M. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_5 · Cited by 2
Alzheimer’s Dementia and Lifestyle: Towards a Primary Prevention
Walach, H., & Loef, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6852-3_12 · Cited by 2
Misfolded Proteins in Neurodegenerative Dementias: Molecular Mechanisms
Yang, H. D., Ho, D. H., Yi, M. J., Seol, W., & Kim, S. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.2.38 · Cited by 2
Standardization of MRI and Amyloid Imaging
Grothe, M. J., Kurth, J., Hampel, H. J., Krause, B. J., & Teipel, S. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00009-2 · Cited by 2
The Pattern of Cortical Lesions in Preclinical Stages
Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_7 · Cited by 3
Self-citationNeurodegeneration and the Ordered Assembly of Tau
Goedert, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00004-3 · Cited by 3
Prions et transconformation protéique: une perspective historique
Hauw, J., Haı̈k, S., & Brandel, J. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30881-7 · Cited by 2
Tam, J. H. K., & Pasternak, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00004-5 · Cited by 2
Costigan, A. G., Umla‐Runge, K., Evans, J., Raybould, R., Graham, K. S., & Lawrence, A. D. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2021.100059 · Cited by 2
Tau in Health and Neurodegenerative Diseases
Chu, D., & Liu, F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101299 · Cited by 2
Diraco, G., Leone, A., & Siciliano, P. A. (2022) · Lecture notes in electrical engineering · doi:10.1007/978-3-031-08838-4_22 · Cited by 2
Ross, I. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-63681-3_6 · Cited by 2
Ordering of Alzheimer Disease Biomarkers
Glodzik, L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2906 · Cited by 2
Ramsden, C. E., Zamora, D., Horowitz, M. S., Jahanipour, J., Keyes, G. S., Li, X., Murray, H. C., Curtis, M. A., Faull, R. L. M., Sedlock, A. B., et al. (2023) · medRxiv · doi:10.21203/rs.3.rs-2968020/v1 · Cited by 2
Bell-Simons, M., Buchholz, S., Klimek, J., & Zempel, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601286 · Cited by 3
Why delay in effective treatment for Alzheimer's disease and related conditions
Iqbal, K., Liu, F., Gong, C., Dai, C., & Hu, W. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.08.002 · Cited by 1
Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool
Sakuragi, S., Uchida, T., Kato, N., Zhao, B., Takahashi, T., Hattori, A., Sakata, Y., Soeda, Y., Takashima, A., Yoshimura, H., et al. (2024) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v21.0023 · Cited by 2
Moreira, I. P., Serrão, P., Sequeira, L., Sá, M. J., Vieira‐Coelho, M. A., & Guimarães, J. (2025) · Neurological Research · doi:10.1080/01616412.2025.2542944 · Cited by 1
Neuropathology and Biomarker Correlates of Late Onset Alzheimer’s Disease in Aged Old World Monkeys
Zeiss, C. J., Duque, A., & Huttner, A. J. (2025) · Toxicologic Pathology · doi:10.1177/01926233251388069 · Cited by 2
Laczó, M., Malenínská, K., Khazaalova, N., Borovská, Š., Vyhnálek, M., HORT, J. F., Stuchlík, A., Svoboda, J., & Laczó, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-36266-y · Cited by 1
Zhang, Y., Zhang, X., Chen, P., Zhou, Z.-Y., Huang, M., & He, K. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71127 · Cited by 1
Wang, Y., Sun, Z., Zhou, P., Tu, T., Zhang, X.-J., Tu, E., Chen, H., Cheng, H.-Y., Pan, A., Zhang, Q., et al. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.03.032 · Cited by 1
AI guided discovery of a murine model of asymptomatic Alzheimer’s disease
Jati, S., Taheri, S., Kal, S., Sinha, S. C., Head, B. P., Mahata, S. K., & Sahoo, D. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02286-y · Cited by 1
Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer’s disease therapy
Ouro, A., Ben-Dor, G. A., Debasa‐Mouce, M., Gulkarov, S., Leon, J. D., Castro‐Mosquera, M., Sobrino, T., Bougea, A. M., & Reiss, A. B. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1766762 · Cited by 1
Structural MRI in frontotemporal dementia and Alzheimer’s disease: stage-dependent atrophy patterns
Khalili, E., Sodaei, F., Noroozıan, M., Michel, T. M., & Vafaee, M. S. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03158-4 · Cited by 1
André, C., Bédard, M., Daneault, V., Wickens, R. H., Fliaguine, O., Soucy, J., Gauthier, S. G., Lorrain, D., Bastien, C., Hudon, C., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03635-y · Cited by 4
Aguilar, L. F., Zaikos, T. D., Rivera, I., Wright, S. T., Lou, J., Gawronski, B., Gonzalez, L., Berry, J. V., Rouanet, J. P., Edwards, N. C., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03028-z · Cited by 1
Stress, stress systems, and Alzheimer's disease
Eberly, S. G., Phumsatitpong, C., Munro, C. E., Neylan, T. C., Kaufer, D., & Ehrenberg, A. J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71542 · Cited by 1
Artificial intelligence–based 3D segmentation of tangle‐associated TDP ‐43 in neurodegeneration
Uruk, G., Youssef, H., Gatto, R. G., Hossain, N., Whitwell, J. L., Reichard, R. R., & Josephs, K. A. (2026) · Brain Pathology · doi:10.1111/bpa.70131 · Cited by 1
Bellver‐Sanchís, A., Ralchev, N., Romanska, P. R., Dyakova, N. K., Ivanova, K. I., Griñán‐Ferré, C., & Marchev, A. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177833 · Cited by 1
Degeneration of the Human Nervous System and Magnetic Resonance Neuroimaging
Lulé, D. E., & Albert, L. (2011) · InTech eBooks · doi:10.5772/24525 · Cited by 1
Hauw, J., Plu, I., Seilhean, D., & Duyckaerts, C. J. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31683-8 · Cited by 1
Prevention of Alzheimer's Disease and Alzheimer's Dementia
Russ, T. C., Ritchie, C. W., & Ritchie, K. A. (2016) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_23-1 · Cited by 1
Okamoto, K., Naito, I., Fukuda, T., Suzuki, K., & Takatama, M. (2017) · Neuropathology · doi:10.1111/neup.12455 · Cited by 1
Prevention of Alzheimer’s Disease and Alzheimer’s Dementia
Russ, T. C., Ritchie, C. W., & Ritchie, K. A. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_23 · Cited by 1
Prion-Like Properties of Assembled Tau Protein
Clavaguera, F., Tolnay, M., & Goedert, M. (2013) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-35491-5_7 · Cited by 1
Zou, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_4 · Cited by 1
Protective Effects of β-Blockers on Bone in Older Adults with Dementia
Khuc, K., Bordes, J. D., Ogunwale, A. N., Madel, M., Ambrose, C. G., Schulz, P. E., Elefteriou, F., Schwartz, A. V., & Rianon, N. J. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01221-4 · Cited by 1
Cognitive Aging and the Transition to Early Alzheimer’s Disease
Mormino, E. C., & Jagust, W. J. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190917982.013.59 · Cited by 1
Puckett, O. K., Fennema‐Notestine, C., Hagler, D. J., Braskie, M. N., Chen, J., Finch, C. E., Kaufman, J. D., Petkus, A. J., Reynolds, C. A., Salminen, L. E., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14344 · Cited by 2
Lloyd, C., Freskgård, P., Newton, P., Lowne, D., Nickson, A. A., Bogstedt, A., Eketjäll, S., Höglund, K., Gustavsson, S., Welsh, F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14238
Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
Sentyabreva, A. V., Vasyukova, O. A., Zorkina, Y., Andryushchenko, A. V., Kostyuk, G. P., Здиславовна, Е. И., & Kosyreva, A. M. (2024) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2024-28-4-488-498 · Cited by 1
Updates in Solving the Mystery of Alzheimer's Disease Pathology
Au, R. (2018) · International Journal of Clinical Pharmacology & Pharmacotherapy · doi:10.15344/2456-3501/2018/138 · Cited by 1
Neurodegenerative Chemosensory Disorders
(2018) · Cambridge University Press eBooks · doi:10.1017/9781139192446.008 · Cited by 1
Using big data methods to understand Alzheimer’s disease
Warren, S. L., Moustafa, A. A., & Alashwal, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821334-6.00004-1 · Cited by 1
Addressing reverse inference in structural brain alterationsPreprint
Cauda, F., Nani, A., Liloia, D., Manuello, J., Premi, E., Duca, S., Fox, P. T., & Costa, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/536847 · Cited by 1
Evaluation of a cognitive and a morphometric marker for the early detection of Alzheimer's disease
Kälin, A. M. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-117647 · Cited by 1
Metadata
- Authors
- Braak, H., & Del Tredici, K.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Braak, Heiko
- ORCID
- Braak, Heiko
- Venue
- Acta Neuropathologica
- Published
- 2010-12-15
- Volume
- 121
- Issue
- 2
- Pages
- 171-181
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2081533023
- Cited by
- 812
- References
- 103
- Citations by year
- 2026: 42 · 2025: 43 · 2024: 58 · 2023: 39 · 2022: 55 · 2021: 74 · 2020: 61 · 2019: 52 · 2018: 51 · 2017: 41 · 2016: 57 · 2015: 52 · 2014: 55 · 2013: 49 · 2012: 45
- FWCI
- 27.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, young adults, tau phosphorylation, neurofibrillary tangles, amyloid-beta, neuritic plaques, subcortical nuclei, AT8 antibody, Down syndrome
- MeSH terms
- Adolescent, Adult, Alzheimer Disease, Brain, Child, Child, Preschool, DNA-Binding Proteins, Female, Humans, Male, Neurons, Phosphorylation, Retrospective Studies, Cohort Studies, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, Ubiquitin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
